Ad Code: Ingrezza - High Opp Display Banners Knowledge Hub - Feb - 216928

A recent article reported on the risk factors, monitoring strategies, and treatment options for tardive dyskinesia to help clinicians improve patient outcomes.

It is important for clinicians to understand the causes and symptoms of tardive dyskinesia to avoid common misdiagnoses and ensure effective management.

A short educational activity on tardive dyskinesia significantly improved clinicians’ confidence in managing and choosing therapies.

Valbenazine and vitamin E are the most effective treatments for tardive dyskinesia, with valbenazine showing the strongest effect size in recent studies.

As this year is nearing the end, PW recaps some of the research presented tardive dyskinesia in 2024. 

Transcranial direct current stimulation shows potential as an effective, safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia.

While uncommon, vocal cord dysfunction related to tardive dyskinesia can occur and may be life-threatening.

Patients and physicians agreed that tardive dyskinesia caused significant work impairment, with some patients completely unable to obtain or maintain a job.

Recent research published in 2024 examined various tardive dyskinesia topics, including: transcranial direct current stimulation; new clinical tool for documenting and rating TD; and schizophrenia-associated genetic markers.

Researchers analyzed whether valbenazine’s impact on tardive dyskinesia symptoms varied between patients with schizophrenia versus bipolar disorder.